Drug research

KT-621

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic DermatitisNCT07217015	KYMR	Phase 2	Active not recruiting	2027-06Estimated
A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma StudyNCT07677059	KYMR	Phase 2	Recruiting	2028-12Estimated
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic AsthmaNCT07323654	KYMR	Phase 2	Recruiting	2027-12Estimated

KYMRActive not recruitingPrimary completion: 2027-06 · Estimated

Trial details

KYMRRecruitingPrimary completion: 2028-12 · Estimated

Trial details

KYMRRecruitingPrimary completion: 2027-12 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.